GLIPIZIDE

Generic: GLIPIZIDE

Rising Pharma HoldingsManufacturer
ORALRoute
GLIPIZIDEActive Substance
2016-12-29Original Approval

GLIPIZIDE is FDA application ANDA204720, sponsored by UNIQUE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2015-03-25
GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage

Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.

Top Reported Reactions

1
BLOOD GLUCOSE INCREASED
5,567 reports
2
NAUSEA
3,760 reports
3
DRUG INEFFECTIVE
3,080 reports
4
DIARRHOEA
3,031 reports
5
FATIGUE
2,680 reports
6
WEIGHT DECREASED
2,274 reports
7
DIZZINESS
2,107 reports
8
DYSPNOEA
2,083 reports
9
VOMITING
1,927 reports
10
BLOOD GLUCOSE DECREASED
1,835 reports